1.
J Am Acad Dermatol
; 83(5): 1523-1526, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-866785
Subject(s)
Biological Products/adverse effects , Coronavirus Infections/immunology , Interleukin-23 Subunit p19/antagonists & inhibitors , Pneumonia, Viral/immunology , Psoriasis/drug therapy , Respiratory Tract Infections/epidemiology , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/adverse effects , Antibodies, Monoclonal, Humanized/administration & dosage , Antibodies, Monoclonal, Humanized/adverse effects , Betacoronavirus/immunology , Biological Products/administration & dosage , COVID-19 , Clinical Decision-Making , Clinical Trials, Phase II as Topic , Clinical Trials, Phase III as Topic , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Humans , Interleukin-23 Subunit p19/metabolism , Odds Ratio , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Psoriasis/immunology , Respiratory Tract Infections/chemically induced , Respiratory Tract Infections/immunology , Respiratory Tract Infections/prevention & control , Risk Assessment , SARS-CoV-2 , Signal Transduction/drug effects , Signal Transduction/immunology
2.
J Am Acad Dermatol
; 84(1): 161-163, 2021 01.
Article
in English
| MEDLINE | ID: covidwho-730886
Subject(s)
COVID-19/epidemiology , Clinical Decision-Making/methods , Immunosuppressive Agents/adverse effects , Psoriasis/drug therapy , Tumor Necrosis Factor Inhibitors/adverse effects , COVID-19/immunology , COVID-19/virology , Clinical Trials, Phase III as Topic , Humans , Pandemics , Psoriasis/immunology , Risk Assessment/statistics & numerical data , SARS-CoV-2/immunology
3.
J Am Acad Dermatol
; 83(2), 2020.
Article
in English
| MEDLINE | ID: covidwho-627770
4.
J Am Acad Dermatol
; 83(4): e305-e306, 2020 10.
Article
in English
| MEDLINE | ID: covidwho-627602